Even before the proposed reorganization of the US Food and Drug Administration’s Office of Regulatory Affairs is completed, the agency’s inspections and investigations functions already are working more closely with the individual product centers, says Michael Rogers, associate commissioner for regulatory affairs.
The most significant change as part of the reorg will involve relocating ORA’s current compliance functions to the product centers, Rogers said during a 1 May
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?